Mounjaro on SilverScript Choice (S5601-024)
tirzepatide injection
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 4 per 365 days.
$44.61
Patient pays / month, after deductible
$178.42
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
MOUNJARO 2.5 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $178.42 for a month. Other covered strengths are listed below.
Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| MOUNJARO 15 mg/.5mL Injection, Solution | 5 | $270.35 | PA · 2 per 28 days |
| MOUNJARO 12.5 mg/.5mL Injection, Solution | 5 | $270.33 | PA · 2 per 28 days |
| MOUNJARO 10 mg/.5mL Injection, Solution | 5 | $270.35 | PA · 2 per 28 days |
| MOUNJARO 7.5 mg/.5mL Injection, Solution | 5 | $270.33 | PA · 2 per 28 days |
| MOUNJARO 5 mg/.5mL Injection, Solution | 5 | $270.33 | PA · 2 per 28 days |
| MOUNJARO 2.5 mg/.5mL Injection, Solution | 5 | $44.61 | PA · 4 per 365 days |
Other GLP-1s on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-024